- Home
- Automated
- NDF A-Z listing
- Papillomavirus (human types 6, 11, 16, 18) Vaccine
Papillomavirus (human types 6, 11, 16, 18) Vaccine
No
No
No
No
General information
Subsidy Information and Financing Scheme
Not Applicable
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Drug availability
Formulation | Public Healthcare Institution |
|---|---|
Gardasil™ Intramuscular Solution, Sterile, Human Papillomavirus Type 11 L1 Protein 40 mcg + Human Papillomavirus Type 16 L1 Protein 40 mcg + Human Papillomavirus Type 18 L1 Protein 20 mcg + Human Papillomavirus Type 6 L1 Protein 20 mcg |
|
List of monographs containing this active ingredient
Papillomavirus (human types 6, 11, 16, 18) Vaccine [Gardasil™]
